PHARMACOGENETICS OF INTRAVENOUS AND ORAL BUSULFAN IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS

Kinetics-based dose targeting is often conducted in hematopoietic cell transplant (HCT) patients conditioned with intravenous (IV) or oral busulfan to lower rates of rejection, nonrelapse mortality, and relapse. Using the candidate gene approach, we evaluated whether busulfan clearance was associate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Abbasi, Nissa, Vadnais, Barbara, Knutson, Jennifer A., Blough, David K., Kelly, Edward J., O’Donnell, Paul V., Deeg, H. Joachim, Pawlikowski, Matthew, Ho, Rodney J. Y., McCune, Jeannine S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117932/
https://ncbi.nlm.nih.gov/pubmed/21135089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0091270010382915
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados